Breaking News

Silab Debuts Anti-Aging Solution

August 27, 2014

Targets tissue damage caused by glycation.

Elasticity loss and tissue stiffening are signs of aging resulting from glycation. To fight against these occurrences, Silab offers Deglysome, a double effect active ingredient capable of limiting cellular and tissue damages caused by glycation and Advanced Glycation End products (AGEs).

According to the company, by reducing production of AGEs and thus glycation of dermal proteins, Deglysome limits the damage caused to fibroblasts and their environment. Rich in sulfated galactans derived from the Hypnea musciformis algae, this novel ingredient is said to protect the cytoskeleton by maintaining vimentin organization and preserving synthesis of the extracellular matrix proteins; as well as support the matrix network by stimulating the formation of collagen and fibrillin networks.

A genuine shield against glycation, Deglysome is recommended for all anti-aging and firming treatments.

More info: www.silab.fr
 
  • Patent Activity: Colgate-Palmolive

    Patent Activity: Colgate-Palmolive

    December 6, 2016
    New oral care compositions, the use of radish root ferment filtrate in a cleanser and more.

  • Sparkle & Shine

    Sparkle & Shine

    Melissa Meisel, Associate Editor||November 21, 2016
    Glam packaging and upscale scent combos are big at Yankee Candle for Holiday 2016.

  • Cos Bar: Turning 40 and Hitting Fast Forward

    Cos Bar: Turning 40 and Hitting Fast Forward

    Christine Esposito, Associate Editor||November 21, 2016
    With a recent investor infusion, a new CEO and rebranding effort underway, this luxury beauty retailer has big plans.

  • The World Comes to Orlando

    The World Comes to Orlando

    Tom Branna , Editorial Director||December 1, 2016
    More than 1,600 chemists traveled to Florida for the IFSCC Congress

  • The Plex  Phenomenon

    The Plex Phenomenon

    Denise Costrini, Croda North America||December 1, 2016
    Croda details the hair-protecting qualities of bond multipliers and the company’s new bond-building formulation system.